Activity Overview
This educational activity is an archive
of the live conference held from January 23 to 25, 2026.
Target Audience
This educational activity is intended for oncologists involved in
the treatment and management of patients with lung cancer. Nurse practitioners,
nurses, physician assistants, pharmacists, clinical investigators, fellows, and
other health care professionals interested in the treatment of lung cancer may
also participate.
Learning Objectives
- Evaluate efficacy and safety data from recent clinical trials on established and emerging therapeutic approaches for lung cancer.
Edgardo S. Santos Castillero, MD, FACP, FASCO
Medical Director- Broward County, Florida
The Oncology Institute of Hope and Innovation
Medical Oncology-Thoracic
Clinical Associate Professor
Charles E. Schmidt College of Medicine
Florida Atlantic University
Vice-President, Florida Society of Clinical Oncology (FLASCO)
President, FLASCO Foundation
Jorge Gomez, MD
Assistant Professor of Medicine (Hematology and Medical Oncology)
Icahn School of Medicine at Mount Sinai
New York, NY
Christina Baik, MD, MPH
Thoracic, Head and Neck Medical Oncology
Fred Hutchinson Cancer Center
University of Washington School of Medicine
Seattle, WA
Panagis Galiatsatos, MD, MHS
Assistant Professor
Johns Hopkins University School of Medicine
Baltimore, MD
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
